Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-05

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' supplemental application for methylphenidate hydrochloride long-acting (LA), a generic ADHD medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate hydrochloride (LA) (Methylphenidate hydrochloride)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (LA) (METHYLPHENIDATE HYDROCHLORIDE)